"...new data shows that a weekly dose of 525 mg and 700 mg of leronlimab yielded approximately a 90% response rate for those HIV-infected patients who pass the first 10 weeks of monotherapy without virologic failure. Approximately 30% of subjects fail within the first 10 weeks of monotherapy on a 525 mg dosage and 17% at a dosage of 700 mg."

Question: Does this mean that overall efficacy at 700mg is now 1*0,83×0,9= 74,7% ?